Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

Early initiation of gonadotropin-releasing hormone antagonist treatment results in a more stable endocrine milieu during the mid- and late-follicular phases: a randomized controlled trial comparing gonadotropin-releasing hormone antagonist initiation on cycle day 2 or 6.

Hamdine O, Broekmans FJ, Eijkemans MJ, Lambalk CB, Fauser BC, Laven JS, Macklon NS; CETRO trial study group.

Fertil Steril. 2013 Sep;100(3):867-74. doi: 10.1016/j.fertnstert.2013.05.031. Epub 2013 Jun 27.

PMID:
23809501
2.

Follicular phase endocrine characteristics during ovarian stimulation and GnRH antagonist cotreatment for IVF: RCT comparing recFSH initiated on cycle day 2 or 5.

Blockeel C, Sterrenburg MD, Broekmans FJ, Eijkemans MJ, Smitz J, Devroey P, Fauser BC.

J Clin Endocrinol Metab. 2011 Apr;96(4):1122-8. doi: 10.1210/jc.2010-2239. Epub 2011 Feb 9.

PMID:
21307142
3.

Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial.

Hamdine O, Macklon NS, Eijkemans MJ, Laven JS, Cohlen BJ, Verhoeff A, van Dop PA, Bernardus RE, Lambalk CB, Oosterhuis GJ, Holleboom CA, van den Dool-Maasland GC, Verburg HJ, van der Heijden PF, Blankhart A, Fauser BC, Broekmans FJ; CETRO trial study group.

Hum Reprod. 2013 Dec;28(12):3227-35. doi: 10.1093/humrep/det374. Epub 2013 Oct 15.

PMID:
24129613
4.

Elevated early follicular progesterone levels and in vitro fertilization outcomes: a prospective intervention study and meta-analysis.

Hamdine O, Macklon NS, Eijkemans MJ, Laven JS, Cohlen BJ, Verhoeff A, van Dop PA, Bernardus RE, Lambalk CB, Oosterhuis GJ, Holleboom CA, van den Dool-Maasland GC, Verburg HJ, van der Heijden PF, Blankhart A, Fauser BC, Broekmans FJ; CETRO trial study group.

Fertil Steril. 2014 Aug;102(2):448-454.e1. doi: 10.1016/j.fertnstert.2014.05.002. Epub 2014 Jun 11. Review.

PMID:
24929258
5.
6.
7.

IVF/ICSI outcomes between cycles with luteal estradiol (E2) pre-treatment before GnRH antagonist protocol and standard long GnRH agonist protocol: a prospective and randomized study.

Ye H, Huang GN, Zeng PH, Pei L.

J Assist Reprod Genet. 2009 Mar;26(2-3):105-11. doi: 10.1007/s10815-009-9300-3. Epub 2009 Feb 19.

8.

Early luteal phase endocrine profile is affected by the mode of triggering final oocyte maturation and the luteal phase support used in recombinant follicle-stimulating hormone-gonadotropin-releasing hormone antagonist in vitro fertilization cycles.

Fatemi HM, Polyzos NP, van Vaerenbergh I, Bourgain C, Blockeel C, Alsbjerg B, Papanikolaou EG, Humaidan P.

Fertil Steril. 2013 Sep;100(3):742-7. doi: 10.1016/j.fertnstert.2013.05.028. Epub 2013 Jun 24.

PMID:
23806846
9.

Exposure to high levels of luteinizing hormone and estradiol in the early follicular phase of gonadotropin-releasing hormone antagonist cycles is associated with a reduced chance of pregnancy.

Kolibianakis EM, Albano C, Kahn J, Camus M, Tournaye H, Van Steirteghem AC, Devroey P.

Fertil Steril. 2003 Apr;79(4):873-80.

PMID:
12749423
10.

Follicular fluid anti-Müllerian hormone and inhibin B concentrations: comparison between gonadotropin-releasing hormone (GnRH) agonist and GnRH antagonist cycles.

Lee JR, Kim SH, Kim SM, Jee BC, Ku SY, Suh CS, Choi YM, Kim JG, Moon SY.

Fertil Steril. 2008 Apr;89(4):860-7. doi: 10.1016/j.fertnstert.2007.04.010. Epub 2008 Feb 4.

PMID:
18249372
11.

Timing of human chorionic gonadotropin (hCG) hormone administration in IVF/ICSI protocols using GnRH agonist or antagonists: a systematic review and meta-analysis.

Chen Y, Zhang Y, Hu M, Liu X, Qi H.

Gynecol Endocrinol. 2014 Jun;30(6):431-7. doi: 10.3109/09513590.2014.895984. Epub 2014 Apr 14. Review.

PMID:
24731070
13.
14.

Supplementation with a recombinant human chorionic gonadotropin microdose leads to similar outcomes in ovarian stimulation with recombinant follicle-stimulating hormone using either a gonadotropin-releasing hormone agonist or antagonist for pituitary suppression.

Cavagna M, Maldonado LG, de Souza Bonetti TC, de Almeida Ferreira Braga DP, Iaconelli A Jr, Borges E Jr.

Fertil Steril. 2010 Jun;94(1):167-72. doi: 10.1016/j.fertnstert.2009.02.075. Epub 2009 Apr 1.

PMID:
19342035
15.
16.

Menstrual cycle synchronization, ovarian stimulation, and in vitro fertilization in olive baboons (Papio anubis): a prospective randomized study.

Nyachieo A, Spiessens C, Chai DC, Mwenda JM, D'Hooghe TM.

Fertil Steril. 2009 Feb;91(2):602-10. doi: 10.1016/j.fertnstert.2007.11.071. Epub 2008 Mar 6.

PMID:
18328482
17.

Microdose gonadotropin-releasing hormone agonist flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protocol in poor responders undergoing intracytoplasmic sperm injection-embryo transfer cycle.

Kahraman K, Berker B, Atabekoglu CS, Sonmezer M, Cetinkaya E, Aytac R, Satiroglu H.

Fertil Steril. 2009 Jun;91(6):2437-44. doi: 10.1016/j.fertnstert.2008.03.057. Epub 2008 Jun 13.

PMID:
18555238
18.

Multifollicular recruitment in combination with gonadotropin-releasing hormone antagonist increased pregnancy rates in intrauterine insemination cycles.

Gómez-Palomares JL, Acevedo-Martín B, Chávez M, Manzanares M, Ricciarelli E, Hernández ER.

Fertil Steril. 2008 Mar;89(3):620-4. Epub 2007 Aug 6.

PMID:
17678911
19.

Can pregnancy rate be improved in gonadotropin-releasing hormone (GnRH) antagonist cycles by administering GnRH agonist before oocyte retrieval? A prospective, randomized study.

Schachter M, Friedler S, Ron-El R, Zimmerman AL, Strassburger D, Bern O, Raziel A.

Fertil Steril. 2008 Oct;90(4):1087-93. Epub 2007 Nov 26.

PMID:
18023439
20.

Supplemental Content

Support Center